VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol. 2012 Jun; 227(2):223-33.
View in:
PubMed
subject areas
Animals
Biomarkers, Tumor
Cell Line, Tumor
Cell Movement
Disease-Free Survival
Female
Gastrointestinal Stromal Tumors
Gene Expression Profiling
Genetic Therapy
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Leiomyosarcoma
Male
Mice
Mice, Inbred NOD
Mice, SCID
Multivariate Analysis
Neoplasm Invasiveness
Oligonucleotide Array Sequence Analysis
Prognosis
Proportional Hazards Models
Receptor Tyrosine Kinase-like Orphan Receptors
RNA Interference
RNA, Messenger
Time Factors
Transfection
Tumor Burden
Uterine Neoplasms
Xenograft Model Antitumor Assays
authors with profiles
ALEXANDER LAZAR